InSpark's healthcare software analyzes blood glucose and other data to provide feedback to people with diabetes, answering important questions about their health such as daily patterns of highs and lows and risk of severe hypoglycemia. The company has licensed a suite of blood glucose pattern recognition technology from the University of Virginia that can be applied to BG data to improve the clinical impact of BG monitoring in the tens of millions of diabetes patients on insulin. InSpark is currently developing Vigilant, an mHealth software system that informs about glycemic variability, daily patterns of highs and lows, and risk of severe hypoglycemia in the next 24 hours. The company aims to deliver this transformational technology to improve health outcomes for millions of people with diabetes worldwide.